Renaissance Technologies’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Renaissance Technologies’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-52,105	Closed	-$138K	–	3945
2020 Q1	$138K	Sell	52,105 -91,936	-64%	-$151K	﹤0.01%	3173
2019 Q4	$170K	Sell	144,041 -21,080	-13%	-$33.7K	﹤0.01%	3227
2019 Q3	$284K	Buy	165,121 +140,521	+571%	+$428K	﹤0.01%	3054
2019 Q2	$117K	Buy	+24,600	New	+$138K	﹤0.01%	3378

Renaissance Technologies's NTGN Position: Q2 2020 in Review

Renaissance Technologies sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 52,105 shares — an estimated $138K sold.

Renaissance Technologies first reported a position in NTGN in Q2 2019 and held it in 4 quarters. The position peaked at $284K in Q3 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Renaissance Technologies reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Renaissance Technologies sold 52,105 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $138K.
Renaissance Technologies first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Renaissance Technologies's Neon Therapeutics, Inc. Common Stock position peaked at $284K in Q3 2019.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.